Picture of Anatara Lifesciences logo

ANR Anatara Lifesciences Income Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual income statement for Anatara Lifesciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue00000
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses3.4222.532.041.46
Operating Profit-3.42-2-2.53-2.04-1.46
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-3.36-2-2.53-2.02-1.45
Provision for Income Taxes
Net Income After Taxes-3.36-2-2.53-2.02-1.45
Net Income Before Extraordinary Items
Net Income-3.36-2-2.53-2.02-1.45
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-3.36-2-2.53-2.02-1.45
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.063-0.029-0.032-0.019-0.01